Why Is LyondellBasell Industries (LYB) Stock Down -13% Today?
Key Takeaways
- Shares of LYB are down approximately 13% in Wednesday's session, sharply underperforming a broadly rallying market
- The primary catalyst is the sudden US-Iran ceasefire announcement on the evening of April 7, which triggered a 15%+ crash in crude oil prices
- LYB had surged roughly 43% year-to-date largely on the "Iran war trade" thesis — that thesis is now being aggressively unwound
- Oil fell from a peak near $117 per barrel to approximately $95/barrel, removing the geopolitical premium that had underpinned LYB's outperformance
- With the broader market rallying on ceasefire news, LYB's selloff reflects a sector-specific reversal of conflict-driven gains
- Traders are now watching whether ceasefire terms hold, and how chemical product prices reprice in the wake of collapsing oil
Opening Summary
LyondellBasell Industries N.V. (LYB) is a Houston, Texas-based multinational chemical company and one of the world's largest producers of polyolefins, petrochemicals, and refined products. LYB shares are down approximately 13% on Wednesday, April 8, trading near $68.40 after closing the prior session at $78.62. The decline is striking against a broader market backdrop that is sharply higher, with the S&P 500 futures up more than 3% on the day. The catalyst is unambiguous: a ceasefire in the US-Iran conflict, announced late on April 7, sent crude oil prices into freefall — and with it, erased the war-premium that had been built into LYB's stock price over the preceding weeks.
US-Iran Ceasefire Triggers Oil Price Collapse
The ceasefire deal, mediated by Pakistani Prime Minister Shehbaz Sharif, prompted President Trump to announce he agreed "to suspend the bombing and attack of Iran for a period of two weeks." The announcement sent shockwaves through energy markets: Brent crude futures plunged roughly 15% to approximately $92.90 per barrel, while West Texas Intermediate fell 16% to around $94.80, after having peaked near $117 per barrel during peak conflict tensions on Tuesday. Natural gas, heating oil, and wholesale gasoline prices all followed lower, with European natural gas declining around 20%. This swift repricing across the entire energy complex directly impacted LYB and other oil-linked commodity chemical producers.
The Iran War Premium Unwinds
LYB had been one of the clearest beneficiaries of the Iran conflict in the equity market. Since the conflict erupted on February 28, 2026, crude oil surged more than 40%, and analysts including KeyBanc and Citigroup explicitly upgraded the stock and raised price targets on the basis of the Iran war thesis. KeyBanc upgraded LYB to "Overweight" in early March, citing the conflict's expected benefit to U.S. petrochemical producers through supply disruptions for global competitors and feedstock cost advantages. With the ceasefire removing that structural tailwind, the market is now rapidly reversing those conflict-driven gains — a textbook "sell the peace" reaction for a stock built on a geopolitical trade.
Bearish Fundamentals Re-emerge
Beyond the conflict unwind, the ceasefire puts a spotlight back on LYB's challenging underlying fundamentals. The company reported a full-year 2025 net loss of $738 million, compared to net income of $1.37 billion in 2024, and posted an adjusted Q4 2025 loss of $0.26 per share — well below analyst expectations of a $0.20 profit. Revenue for 2025 declined 9.7% to $30.15 billion. With oil-linked product prices set to follow crude lower, the near-term earnings recovery thesis weakens considerably. The North American Olefins and Polyolefins segment had already seen a 53% drop in operational performance heading into 2026, driven by compressed ethylene margins and oversupplied oxyfuels markets.
Market Context and Trading Activity
Wednesday's session is notable for the stark divergence between LYB and the broader market. U.S. stock futures surged — the Dow soared over 1,100 points, Nasdaq 100 futures rose 3.5%, and S&P 500 futures climbed more than 3.5% — as investors cheered reduced geopolitical risk and renewed Federal Reserve rate cut expectations. Trading volume in LYB is notably elevated, consistent with a sharp institutional unwind of the "Iran conflict trade." Peer chemical stocks and energy-linked equities are experiencing similar pressure as the sector rerate plays out. The stock has broken below several near-term technical support levels, reflecting a broad recalibration of the war-premium embedded in energy and chemical equities since late February.
Trending AI Robots
For traders navigating volatile sessions like today's, Tickeron's Trending AI Robots page surfaces the platform's top-performing automated trading bots under current market conditions. Tickeron offers hundreds of AI-powered trading bots spanning thousands of tickers, strategies, and timeframes — but only those demonstrating the strongest live performance metrics are featured in the curated Trending section. Bots vary by approach, including momentum, mean-reversion, and swing strategies, each with distinct risk profiles and traded instruments. Whether you're managing risk in a fast-moving session or seeking systematic exposure, reviewing the Trending AI Robots lineup offers a data-driven starting point for identifying which automated strategies are currently working best in live markets.
What Comes Next for LYB
The most immediate variable for LYB is whether the US-Iran ceasefire holds. The two-week ceasefire is explicitly conditional, and any breakdown in negotiations could quickly revive oil prices and restore some of the conflict premium. Analysts consensus sits at "Hold" as of April 8, 2026, with 16 analysts monitored. The company's next earnings report will be closely watched for early indicators of how sharply product prices have moved and whether the $1.3 billion cost improvement program is offsetting revenue headwinds. LYB's management has flagged ongoing weakness in styrene margins, oversupplied oxyfuels, and compressed ethylene spreads as persistent challenges regardless of macro backdrop. Investors will also monitor whether major sell-side firms that upgraded LYB on the Iran thesis — including KeyBanc and Citigroup — revisit their ratings in light of the ceasefire.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
LYB in upward trend: price may jump up because it broke its lower Bollinger Band on September 18, 2026
LYB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 40 cases where LYB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LYB's RSI Oscillator exited the oversold zone, 16 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 60 cases where LYB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on LYB as a result. In 64 of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for LYB just turned positive on October 08, 2026. Looking at past instances where LYB's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.
Following a +2.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in 183 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Bearish Trend Analysis
LYB moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LYB crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for LYB entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.764) is normal, around the industry mean (6.363). P/E Ratio (98.766) is within average values for comparable stocks, (209.940). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (1.548). LYB's Dividend Yield (0.059) is considerably higher than the industry average of (0.013). P/S Ratio (0.670) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. LYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of petrochemicals
Industry ChemicalsSpecialty
Advertisement